A dose-dependent inhibitory effect of cyclosporine A on obliterative bronchiolitis of rat tracheal allografts

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 1, 1997, Pages 303-312

  Koskinen, Petri K ^b   Kallio, Erkki A ^b   Krebs, Rainer ^b   Lemström, Karl B ^a  

^a Transplantation Laboratory   (Finland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

15 DEOXYSPERGUALIN; CYCLOSPORIN A; INTERLEUKIN 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BRONCHITIS; DOSE RESPONSE; GRANULATION TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LYMPHOCYTE PROLIFERATION; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY EPITHELIUM; T LYMPHOCYTE ACTIVATION; TRACHEA;

EID: 0031017526     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.1.9001329     Document Type: Article

References (29)

1. Grossman, R. F., A. Frost, N, Zamel, G. A. Patterson, J. D. Cooper, P. R. Myron, C. L. Dear, and J. Maurer. 1990. Results of singlelung transplantation for bilateral pulmonary fibrosis. N. Engl. J. Med. 322:727-733.
2. Hosenpud, J. D., R. J. Novick, T. J. Breen, and O. P. Daily. 1994. The registry of the international society for heart and lung transplantation: eleventh official report-1994. J. Heart Lung Transplant. 13: 561-570.
3. Burke, C. M., J. Theodore, K. D. Dawkins, S. A. Yousem, N. Blank, M. E. Billingham, A. Van Kessel, S. W. Jamieson, P. E. Oyer, J. C. Baldwin, E. B. Stinson, N. E. Shumway, and E. D. Robin. 1984. Posttransplant obliterative bronchiolitis and other late lung sequelae in human heart-lung transplantation. Chest 86:824-829.
4. Yousem, S. A., J. M. Curley, J. Dauber, I. Paradis, H. Rabinowich, A. Zeevi, R. Duquesnoy, R. Dowling, M. Zenati, R. Hardesty, and B. P, Griffith. 1990. HLA-class II antigen expression in human heart-lung allografts. Transplantation 49:991-995.
5. Yousem, S. A., L. Ray, I. L. Paradis, J. A. Dauber, and B. P. Griffith. 1990. Potential role of dendritic cells in bronchiolitis obliterans in human heart-lung transplantation. Ann. Thorac. Surg. 49:424-428.
6. Yousem, S. A., G. J. Berry, E. M. Brunt, D. Chamberlein, R. H. Hruban, R. K. Sibley, S. Stewart, and H. D. Tazelaar. 1990. A working formulation for the standardization in the diagnosis of heart and lung rejection: lung rejection study group. J. Heart Lung Transplant. 9: 593-601.
7. Hertz, M. I., J. Jessurun, M. B. King, S. Kay Savik, and J. J. Murray. 1993. Reproduction of the obliterative bronchiolitis lesion after heterotopic transplantation of mouse airways. Am. J. Pathol. 142: 1945-1951.
8. Mayer, E., P. F. Cardoso, J. D. Puskas, K. De-Campos, T. Oka, I. Dardick, and G. A. Patterson. 1992. The effect of basic fibroblast growth factor and omentopexy on revascularization and epithelial regeneration of heterotopic rat tracheal isografts. J. Thorac. Cardiovasc. Surg. 104:180-188.
9. Magaud, J.-P., I. Sargent, P. J. Clarke, M. Ffrench, R. Rimokh, and D. Y. Mason. 1989. Double immunocytochemical labeling of cell and tissue samples with monoclonal anti-bromodeoxyuridine. J. Histochem. Cytochem. 37:1517-1527.
10. Uyama, T., J. B. Winter, G. Groen, C. R. H. Wildevuur, Y. Monden, and J. Prop. 1992. Late airway changes caused by chronic rejection in rat lung allografts. Transplantation 54:809-812.
11. Al-Dossari,G. A., J. Jesserun, M. Bolman, III, V. R. Kshettry, M. B. King, J. J. Murray, and M. I. Hertz. 1994. Pathogenesis of obliterative bronchiolitis. Possible role of platelet-derived growth factor and basic fibroblast growth factor. Transplantation 59:143-145.
12. Häyry, P., H. Isoniemi, S. Yilmaz, A. Mennander, K. Lemström, A. Räisänen-Sokolowski, P. Koskinen, J. Ustinov, I. Lautenschlager, E. Taskinen, L. Krogerus, P. Aho, and T. Paavonen. 1993. Chronic allograft rejection, Immunol. Rev. 134:33-81.
13. Herzt, M. I., C. A. Henke, R. E. Nakhleh, K. R, Harmon, W. A. Marinelli, J. M. K. Fox, S. H. Kubo, S. J. Shumway, R. M. Bolman, III, and P. B. Bitterman. 1992. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 89:10358-10389.
14. Koskinen, P., K. Lemström, and P. Häyry. 1995. How cyclosporine modifies histologic and molecular events in the vascular wall during chronic rejection of rat heart allografts. Am. J. Pathol. 146:972-980.
15. Ferns, G., M. Reidy, and R. Ross. 1990. Vascular effects of cyclosporine A in vivo and in vitro. Am. J. Pathol. 137:403-413.
16. Jonasson, L., J. Holm, and G. K. Hansson. 1988. Cyclosporine A inhibits smooth muscle cell proliferation in the vascular response to injury. Proc. Natl. Acad. Sci. U.S.A. 85:2303-2306.
17. Spurzem, J. R., O. Sacco, G. A. Rossi, J. D. Beckman, and S. I. Rennard. 1992. Regulation of major histocompatibility complex class II gene expression on bovine bronchial epithelial cells. J. Lab. Clin. Med. 120:94-102.
18. Davreux, C. J., N. H. Chu, T. K. Waddell, E. Mayer, and A. Patterson. 1993. Improved tracheal allograft viability in immunosuppressed rats. Ann. Thorac. Surg. 55:131-134.
19. Räisänen-Sokolowski, A., S. Yilmaz, G. Tufveson, and P. Häyry. 1994. Partial Inhibition of allograft arteriosclerosis (chronic rejection) by 15-deoxyspergualin. Transplantation 57:1772-1777.
20. Räisänen-Sokolowksi, A., P. Aho, M. Myllärniemi, E. Kallio, and P. Häyry. 1995. Inhibition of early chronic rejection in rat aortic allograft by mycophenolate mofetil (RS61443). Transplant. Proc. 27:435.
21. Ochiai, T., K. Nakajima, K. Sakamoto, M. Nagata, Y. Gunji, T. Asano, K. Isono, T. Sakamaki, and K. Hamaguchi. 1989. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine. Transplant. Proc. 21:829-832.
22. Kerr, P. G., and R. C. Atkins. 1989. The effects of deoxyspergualin on lymphocytes and monocytes in vivo and in vitro. Transplantation 48:1048-1052.
23. Makino, M., M. Fujiwara, H. Watanabe, T. Aoyagi, and H. Umezawa. 1987. Immunosuppressive activities of deoxyspergualin: II. The effect on the antibody response. Immunopharmacology 14:115-122.
24. Amemiya, H., S. Suzuki, K. Ota, K. Takahashi, T. Sonoda, M. Ishibashi, R. Omoto, I. Koyama, K. Dohi, Y. Fukuda, and K. Fukao. 1990. A novel rescue drug, 15-deoxyspergualin. Transplantation 49:337-343.
25. Jiang, H., S. Takahara, M. Kyo, Y. Takano, Y. Kokado, M. Ishibashi, A. Okuyama, and T. Sonoda. 1992. In vivo and in vitro mechanism of cardiac allograft acceptance in the rat after short treatment with 15-deoxyspergualin. Transplant. Int. 5:139-144.
26. Allison, A. C., E. M. Eugui, and H. W. Sollinger. 1993. Mycophenolate mofetil (RS-61443): mechanisms of action and effects in transplantation. Transplant. Rev. 7:129-139.
27. Taylor, D. O., R. D. Ensly, S. L. Olsen, D. Dunn, and D. G. Renlund. 1994. Mycophenolate mofetil (RS-61443): preclinical, clinical, and three-year experience in heart transplantation. J. Heart Lung Transplant. 13:571-582.
28. Morris, R. E., J. Wang, J. R. Blum, T. Flavin, M. P. Murphy, S. J. Almquist, N. Chu, Y. L. Tam, M. Kaloostian, and A. C. Allison. 1991. Immunosuppressive effects of the morpholonoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts. Transplant. Proc. 23(Suppl. 2):19-25.
29. Gregory, C., R. E. Morris, R. Pratt, M. Billingham, and R. Shorthouse. 1992. The use of new antiproliferative immunosuppressants is a novel and highly effective strategy for the prevention of vascular occlusive disease (abstract). J. Heart Lung Transplant. 11:197.